Folgen
Marc J. Brehme, PhD, MBA
Marc J. Brehme, PhD, MBA
Founder & Managing Director, M-B-V-C
Bestätigte E-Mail-Adresse bei m-b-v-c.com - Startseite
Titel
Zitiert von
Zitiert von
Jahr
A proteome-scale map of the human interactome network
T Rolland, M Taşan, B Charloteaux, SJ Pevzner, Q Zhong, N Sahni, S Yi, ...
Cell 159 (5), 1212-1226, 2014
14502014
A chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease
M Brehme, C Voisine, T Rolland, S Wachi, JH Soper, Y Zhu, K Orton, ...
Cell reports 9 (3), 1135-1150, 2014
5742014
A core transcriptional network for early mesoderm development in Drosophila melanogaster
T Sandmann, C Girardot, M Brehme, W Tongprasit, V Stolc, EEM Furlong
Genes & development 21 (4), 436-449, 2007
3612007
Charting the molecular network of the drug target Bcr-Abl
M Brehme, O Hantschel, J Colinge, I Kaupe, M Planyavsky, T Köcher, ...
Proceedings of the National Academy of Sciences 106 (18), 7414-7419, 2009
2122009
A genome-wide screen identifies the evolutionarily conserved KEOPS complex as a telomere regulator
M Downey, R Houlsworth, L Maringele, A Rollie, M Brehme, S Galicia, ...
Cell 124 (6), 1155-1168, 2006
2112006
Model systems of protein-misfolding diseases reveal chaperone modifiers of proteotoxicity
M Brehme, C Voisine
Disease models & mechanisms 9 (8), 823-838, 2016
602016
A systematic atlas of chaperome deregulation topologies across the human cancer landscape
A Hadizadeh Esfahani, A Sverchkova, J Saez-Rodriguez, AA Schuppert, ...
PLoS computational biology 14 (1), e1005890, 2018
502018
STAT3‐dependent analysis reveals PDK4 as independent predictor of recurrence in prostate cancer
M Oberhuber, M Pecoraro, M Rusz, G Oberhuber, M Wieselberg, ...
Molecular Systems Biology 16 (4), e9247, 2020
402020
In silico prioritization of transporter–drug relationships from drug sensitivity screens
A César-Razquin, E Girardi, M Yang, M Brehme, J Saez-Rodriguez, ...
Frontiers in Pharmacology 9, 412503, 2018
212018
Combined population dynamics and entropy modelling supports patient stratification in chronic myeloid leukemia
M Brehme, S Koschmieder, M Montazeri, M Copland, VG Oehler, ...
Scientific Reports 6 (1), 24057, 2016
172016
Proteostasis network deregulation signatures as biomarkers for pharmacological disease intervention
M Brehme, A Sverchkova, C Voisine
Current Opinion in Systems Biology 15, 74-81, 2019
142019
A global protein–lipid interactome map
M Brehme, M Vidal
Molecular Systems Biology 6 (1), 443, 2010
92010
Personalized medicine in Austria: expectations and limitations
M Pot, M Brehme, A El-Heliebi, B Gschmeidler, P Hofer, T Kroneis, ...
Personalized medicine 17 (06), 423-428, 2020
52020
Advancing biomarker development through convergent engagement: summary report of the 2nd International danube symposium on biomarker development, molecular imaging and applied …
MS Lim, T Beyer, A Babayan, M Bergmann, M Brehme, A Buyx, J Czernin, ...
Molecular imaging and biology 22, 47-65, 2020
42020
HSP90 et al.: chaperome and proteostasis deregulation in human disease
C Voisine, M Brehme
Heat Shock Protein 90 in Human Diseases and Disorders, 591-603, 2019
32019
A Literature-Derived Entrepreneurial Framework for Organizational Development towards Ambidexterity
M Brehme
Technische Universität Wien, 2023
2023
STAT3-dependent systems-level analysis reveals PDK4 as an independent predictor of biochemical recurrence in prostate cancer
M Oberhuber, M Pecoraro, M Rusz, G Oberhuber, M Wieselberg, ...
bioRxiv, 770701, 2019
2019
Computational Analysis of Transporter Repertoires as Determinants of Cellular Cancer Drug Response
P Buphamalai
2016
The chaperome as a therapeutic space in aging and neurodegenerative diseases
C Voisine, M Brehme, T Rolland, S Wachi, K Orton, P Reinhart, M Vidal, ...
MOLECULAR BIOLOGY OF THE CELL 23, 2012
2012
Intercell–accelerating innovation
M Brehme
New biotechnology 25 (4), 181-184, 2009
2009
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20